Vanguard Group’s ImageneBio, Inc. Common Stock IMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.89M | Buy |
117,804
+2,519
| +2% | +$40.5K | ﹤0.01% | 3551 |
|
|
2025
Q1 | $1.77M | Sell |
115,285
-104
| -0.1% | -$1.6K | ﹤0.01% | 3528 |
|
|
2024
Q4 | $2.27M | Hold |
115,389
| – | – | ﹤0.01% | 3526 |
|
|
2024
Q3 | $2.4M | Buy |
115,389
+1,683
| +1% | +$34.9K | ﹤0.01% | 3497 |
|
|
2024
Q2 | $2.25M | Sell |
113,706
-13,975
| -11% | -$277K | ﹤0.01% | 3520 |
|
|
2024
Q1 | $2.18M | Buy |
127,681
+610
| +0.5% | +$10.4K | ﹤0.01% | 3567 |
|
|
2023
Q4 | $3M | Buy |
127,071
+14,322
| +13% | +$339K | ﹤0.01% | 3456 |
|
|
2023
Q3 | $5.86M | Buy |
112,749
+21,485
| +24% | +$1.12M | ﹤0.01% | 3177 |
|
|
2023
Q2 | $7.18M | Buy |
91,264
+8,048
| +10% | +$634K | ﹤0.01% | 3131 |
|
|
2023
Q1 | $3.45M | Buy |
83,216
+1,590
| +2% | +$65.8K | ﹤0.01% | 3476 |
|
|
2022
Q4 | $2.61M | Buy |
81,626
+42
| +0.1% | +$1.34K | ﹤0.01% | 3569 |
|
|
2022
Q3 | $3.48M | Buy |
81,584
+25,409
| +45% | +$1.08M | ﹤0.01% | 3509 |
|
|
2022
Q2 | $2.99M | Sell |
56,175
-9,658
| -15% | -$514K | ﹤0.01% | 3630 |
|
|
2022
Q1 | $4.82M | Buy |
65,833
+633
| +1% | +$46.3K | ﹤0.01% | 3548 |
|
|
2021
Q4 | $9.81M | Buy |
65,200
+13,476
| +26% | +$2.03M | ﹤0.01% | 3215 |
|
|
2021
Q3 | $7.83M | Buy |
51,724
+24,340
| +89% | +$3.69M | ﹤0.01% | 3387 |
|
|
2021
Q2 | $4.61M | Buy |
27,384
+22,384
| +448% | +$3.77M | ﹤0.01% | 3647 |
|
|
2021
Q1 | $1.7M | Buy |
+5,000
| New | +$1.7M | ﹤0.01% | 3902 |
|